Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2005
10/26/2005CN1688885A Assay for beta cell toxic macrolides
10/26/2005CN1688270A Topical patch and reagent kit containing a delayed-type hypersensitivity inducer
10/26/2005CN1686571A Magnetic resonance radiography reinforcing coating composition used for interposing catheter or device and its preparation method
10/26/2005CN1686570A X-ray contrast agent composition and its preparation method
10/26/2005CN1686569A Early senile dementia alpha beta starch spot imaging agent
10/26/2005CN1686568A Establishing method of cervix cancer animal model
10/26/2005CN1686567A Establishment of C578L/6 mouse animal model of transbuman senile dementia APP gene and use
10/26/2005CN1224424C Thermosetting medical carrier composition with mucosa adsorption
10/25/2005US6958140 Methods of imaging and targeting vasculature
10/25/2005CA2284879C Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
10/20/2005WO2005098428A2 Method and system for screening compounds for muscular and/or neurological activity in animals
10/20/2005WO2005098020A1 Assay method for determining mucosal neutrophil counts in neutropenia patients
10/20/2005WO2005098008A1 Lipid-diet inducible heart attack murine model
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097677A1 Embolization
10/20/2005WO2005097672A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy
10/20/2005WO2005097208A2 Tissue oxygenation measurements
10/20/2005WO2005097144A1 Composition for cleaning intestinal canal
10/20/2005WO2005097073A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
10/20/2005WO2005096919A2 Methods of measuring ejaculatory latency times
10/20/2005WO2005096789A2 Methods and compositions for imaging and biomedical applications
10/20/2005WO2005065041A3 Display for computer-aided evaluation of medical images and for establishing clinical recommendation therefrom
10/20/2005WO2005041756A3 Skin test for detecting non-allergic hypersensitivity
10/20/2005WO2005027954A3 Sincalide formulations
10/20/2005WO2005021494A3 D-amino acid peptides
10/20/2005WO2005017539A3 Imaging pathology
10/20/2005US20050234221 genetic vectors, host cells and nucleotide sequences that code polypeptides, agonists and antagonists, that preferentially bind to interleukins, used for diagnosis oro prophylaxis of diseases
10/20/2005US20050233307 Site-specific labeling of affinity tags in fusion proteins
10/20/2005US20050233306 Retentate chromatography and protein chip arrays with applications in biology and medicine
10/20/2005US20050232984 Non-vesicular cationic lipid formulations
10/20/2005US20050232924 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
10/20/2005US20050232916 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
10/20/2005US20050232866 Biochemically-activated contrast agents for magnetic resonance imaging
10/20/2005US20050232865 Microbubble-generating carbohydrate microparticles encapsulated in biodegradable, crosslinked protein shells for enhanced echocardiographic imaging
10/20/2005US20050232864 Method for phenotyping using nmr spectroscopy
10/20/2005US20050232862 Combination therapy for the treatment of estrogen-sensitive drugs
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2561168A1 Three time point lung cancer detection, diagnosis and assessment of prognosis
10/20/2005CA2560312A1 Embolization
10/20/2005CA2557448A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
10/19/2005EP1585549A2 Improved gastrin releasing peptide compounds
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005EP1152061B1 Method for screening physiologically active pyrrole imidazole derivative
10/19/2005EP1061905B1 Compositions for detection and diagnosis of infectious mycobacterial diseases
10/19/2005EP1036057B1 Radio-opaque polymer biomaterials
10/19/2005EP0968013B1 Coated implantable medical device
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005CN1684973A Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
10/19/2005CN1684710A Bifunctional contrast agent comprising a fluorescent dye and an MRI contrast agent
10/19/2005CN1683019A Method and use for constructing AIDS primate model
10/18/2005US6956145 Immune deficient (i.e. severe combined immunodeficiency disease, SCID) mouse having a human prostate cancer xenograft of locally advanced or metastatic prostate cancer
10/18/2005US6955639 Methods of enhancing radiation effects with metal nanoparticles
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/13/2005WO2005095356A1 Agent for generating heat or singlet oxygen and composition for cancer treatment each comprising organic peroxide or chemiluminescent compound
10/13/2005WO2005094903A2 Contrast agents for magnetic resonance imaging
10/13/2005WO2005094902A2 Nanoparticles comprising luminescent substances as contrast agent for optical imaging
10/13/2005WO2005094901A1 Formulations and methods to prepare inhalable buffered methacholine chloride solutions.
10/13/2005WO2005094821A1 A medical composition for increasing the medicine safety
10/13/2005WO2005094364A2 Iga antibody protein as a cytotoxic drug
10/13/2005WO2005094327A2 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
10/13/2005WO2005094285A2 Percutaneous chemical sensor based on fluorescence resonant energy transfer (fret)
10/13/2005US20050228053 Atamestane and toremifene dosage forms and kits for use treating breast cancer
10/13/2005US20050227300 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors
10/13/2005US20050226935 Embolization
10/13/2005US20050226815 cyanine dyes with carboxylic acid or an aryl group; for tumor imaging or angiography; excellent in permeability in a living tissue; enables specific imaging of tumor and/or blood vessel
10/13/2005US20050226814 Diagnostic method and kit for implantation of a sustained release drug-delivery implant with a steroid
10/13/2005US20050226810 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
10/13/2005DE102004015179A1 Antigen des PM-2 Antikörpers und dessen Verwendung Antigen of the PM-2 antibody and the use thereof
10/13/2005CA2561111A1 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
10/12/2005EP1584628A2 Viral protein
10/12/2005EP1584334A2 Solution based methacholine formulations
10/12/2005EP1583473A2 Nanoparticle based stabilization of ir fluorescent dyes
10/12/2005EP1483561A4 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor
10/12/2005EP1259814B1 Bcmp-7 as marker for diagnosis of breast cancer
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1680590A Platform for screening related gene by antisense nucleic acid technology and disease animal model
10/12/2005CN1680432A Viral protein
10/12/2005CN1679968A Medical supersonic conductive gel
10/12/2005CN1679967A Production of mouse model of viral hepatitis B with high expression HBsAg
10/12/2005CN1679955A Compositions for improving drug safety
10/12/2005CN1679928A Compositions for detection and diagnosis of infectious mycobacterial diseases
10/12/2005CN1679625A Medical use of engrafted nanometer carbon
10/12/2005CN1222526C Chlorophyll and bacteriochlorophyll esters, and their preparation
10/11/2005US6953675 Landscaped antibodies and antibody fragments for clinical use
10/11/2005US6953658 Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
10/11/2005US6953569 Mixed gas microbubble compositions
10/11/2005CA2167921C Biodegradable particles
10/06/2005WO2005093422A2 Carbohydrate-encapsulated quantum dots for biological imaging
10/06/2005WO2005092922A2 Antigen of the pm-2 antibody and use thereof
10/06/2005WO2005092396A1 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide
10/06/2005WO2005092375A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005WO2005091750A2 Method and materials for use in diagnosing viral myocarditis
10/06/2005WO2005091704A2 Magnetic nanoparticles of noble metals
10/06/2005WO2005053752A3 Novel imaging agents comprising caspase-3 inhibitors
10/06/2005WO2005025518A3 Inhibition of inward sodium currents in cancer
10/06/2005WO2004112563A3 Gastrointestinal methods and apparatus for use in treating disorders
10/06/2005US20050223420 Inducible heart attack animal model
10/06/2005US20050222014 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture
10/06/2005US20050221270 Process for identifying and treating cells types within a living organism
10/06/2005US20050220715 Methods and compositions for improving drug safety
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 354